Cargando…

Correlation of MMP-3 and MMP-9 with Crohn’s Disease Activity in Children

BACKGROUND: Recently published data indicate that the inflammation in Crohn’s disease (CD) may be accompanied by elevated levels of matrix metalloproteinases. AIMS: The goals of the present study were the estimation of MMP-3 and -9 concentrations in sera of children with Crohn’s disease, the examina...

Descripción completa

Detalles Bibliográficos
Autores principales: Kofla-Dlubacz, Anna, Matusiewicz, Malgorzata, Krzystek-Korpacka, Malgorzata, Iwanczak, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282895/
https://www.ncbi.nlm.nih.gov/pubmed/21997756
http://dx.doi.org/10.1007/s10620-011-1936-z
_version_ 1782224140434931712
author Kofla-Dlubacz, Anna
Matusiewicz, Malgorzata
Krzystek-Korpacka, Malgorzata
Iwanczak, Barbara
author_facet Kofla-Dlubacz, Anna
Matusiewicz, Malgorzata
Krzystek-Korpacka, Malgorzata
Iwanczak, Barbara
author_sort Kofla-Dlubacz, Anna
collection PubMed
description BACKGROUND: Recently published data indicate that the inflammation in Crohn’s disease (CD) may be accompanied by elevated levels of matrix metalloproteinases. AIMS: The goals of the present study were the estimation of MMP-3 and -9 concentrations in sera of children with Crohn’s disease, the examination of correlation between the concentrations of MMP-3 and -9 and clinical activity of the disease in the relation to the control group and the evaluation of the utility of MMP-3 and -9 concentration measurements as markers of disease activity. METHODS: Serum concentrations of MMP-3 and -9 were estimated in 82 children (45 CD patients divided into severe, moderate and mild subgroups; 37 controls) and correlated with disease activity estimated by the Pediatric Crohn’s Disease Activity Index (PCDAI), CRP, seromucoid and ESR. RESULTS: Mean MMP-3 concentrations were: 2.49 ng/ml (95% CI: 1.76–3.52) for mild, 16.44 ng/ml (95% CI: 10.34–26.15) for moderate, 5.25 ng/ml (95% CI: 2.73–10.11) for severe CD and 1.95 ng/ml (95% CI: 1.53–2.48) for the control group (differences between all three groups were statistically significant; P < 0.001). Median MMP-9 concentrations were: 2.14 ng/ml (95% CI: 0–8.9) for mild, 14.21 ng/ml (95% CI: 4.53–21.48) for moderate, 42.2 ng/ml (95% CI: 5.74–61.27) for severe CD and 1.3 ng/ml (95% CI: 0.7–2.18) for the control group. MMP-9 concentrations in moderate and severe CD differed from the concentrations in mild CD (P = 0.002) and control group (P = 0.0001). MMP-3 concentration significantly correlated with MMP-9, PCDAI and ESR, while MMP-9 concentration significantly positively correlated with MMP-3, PCDAI, and CRP. Diagnostic utilities of the tests were: MMP-3 accuracy 75%, positive likelihood ratio (LR+) = 4.11 and negative likelihood ratio (LR−) = 0.51, sensitivity 56%, specificity 87%, Youden index 0.43; for MMP-9, accuracy 73%, LR+ = 5.14 and LR− = 0.50, sensitivity 56%, specificity 89%, Youden index 0.45; and for CRP, accuracy 74%, LR+ = 8.56 and LR− = 0.54, sensitivity 49%, specificity 94%, Youden index 0.43. CONCLUSIONS: MMP-9 serum concentration increasing along with the activity of the disease, exhibiting high specificity and correlating well with the indices of inflammation might be of better usefulness in the prediction of CD activity status in children than MMP-3.
format Online
Article
Text
id pubmed-3282895
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-32828952012-03-01 Correlation of MMP-3 and MMP-9 with Crohn’s Disease Activity in Children Kofla-Dlubacz, Anna Matusiewicz, Malgorzata Krzystek-Korpacka, Malgorzata Iwanczak, Barbara Dig Dis Sci Original Article BACKGROUND: Recently published data indicate that the inflammation in Crohn’s disease (CD) may be accompanied by elevated levels of matrix metalloproteinases. AIMS: The goals of the present study were the estimation of MMP-3 and -9 concentrations in sera of children with Crohn’s disease, the examination of correlation between the concentrations of MMP-3 and -9 and clinical activity of the disease in the relation to the control group and the evaluation of the utility of MMP-3 and -9 concentration measurements as markers of disease activity. METHODS: Serum concentrations of MMP-3 and -9 were estimated in 82 children (45 CD patients divided into severe, moderate and mild subgroups; 37 controls) and correlated with disease activity estimated by the Pediatric Crohn’s Disease Activity Index (PCDAI), CRP, seromucoid and ESR. RESULTS: Mean MMP-3 concentrations were: 2.49 ng/ml (95% CI: 1.76–3.52) for mild, 16.44 ng/ml (95% CI: 10.34–26.15) for moderate, 5.25 ng/ml (95% CI: 2.73–10.11) for severe CD and 1.95 ng/ml (95% CI: 1.53–2.48) for the control group (differences between all three groups were statistically significant; P < 0.001). Median MMP-9 concentrations were: 2.14 ng/ml (95% CI: 0–8.9) for mild, 14.21 ng/ml (95% CI: 4.53–21.48) for moderate, 42.2 ng/ml (95% CI: 5.74–61.27) for severe CD and 1.3 ng/ml (95% CI: 0.7–2.18) for the control group. MMP-9 concentrations in moderate and severe CD differed from the concentrations in mild CD (P = 0.002) and control group (P = 0.0001). MMP-3 concentration significantly correlated with MMP-9, PCDAI and ESR, while MMP-9 concentration significantly positively correlated with MMP-3, PCDAI, and CRP. Diagnostic utilities of the tests were: MMP-3 accuracy 75%, positive likelihood ratio (LR+) = 4.11 and negative likelihood ratio (LR−) = 0.51, sensitivity 56%, specificity 87%, Youden index 0.43; for MMP-9, accuracy 73%, LR+ = 5.14 and LR− = 0.50, sensitivity 56%, specificity 89%, Youden index 0.45; and for CRP, accuracy 74%, LR+ = 8.56 and LR− = 0.54, sensitivity 49%, specificity 94%, Youden index 0.43. CONCLUSIONS: MMP-9 serum concentration increasing along with the activity of the disease, exhibiting high specificity and correlating well with the indices of inflammation might be of better usefulness in the prediction of CD activity status in children than MMP-3. Springer US 2011-10-14 2012 /pmc/articles/PMC3282895/ /pubmed/21997756 http://dx.doi.org/10.1007/s10620-011-1936-z Text en © The Author(s) 2011 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original Article
Kofla-Dlubacz, Anna
Matusiewicz, Malgorzata
Krzystek-Korpacka, Malgorzata
Iwanczak, Barbara
Correlation of MMP-3 and MMP-9 with Crohn’s Disease Activity in Children
title Correlation of MMP-3 and MMP-9 with Crohn’s Disease Activity in Children
title_full Correlation of MMP-3 and MMP-9 with Crohn’s Disease Activity in Children
title_fullStr Correlation of MMP-3 and MMP-9 with Crohn’s Disease Activity in Children
title_full_unstemmed Correlation of MMP-3 and MMP-9 with Crohn’s Disease Activity in Children
title_short Correlation of MMP-3 and MMP-9 with Crohn’s Disease Activity in Children
title_sort correlation of mmp-3 and mmp-9 with crohn’s disease activity in children
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282895/
https://www.ncbi.nlm.nih.gov/pubmed/21997756
http://dx.doi.org/10.1007/s10620-011-1936-z
work_keys_str_mv AT kofladlubaczanna correlationofmmp3andmmp9withcrohnsdiseaseactivityinchildren
AT matusiewiczmalgorzata correlationofmmp3andmmp9withcrohnsdiseaseactivityinchildren
AT krzystekkorpackamalgorzata correlationofmmp3andmmp9withcrohnsdiseaseactivityinchildren
AT iwanczakbarbara correlationofmmp3andmmp9withcrohnsdiseaseactivityinchildren